Search results
Mavenclad and cost: Reducing long-term drug costs and more
Medical News Today· 17 hours agoMavenclad (cladribine) is a brand-name oral tablet that’s prescribed for certain types of multiple...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist - WTOP News
WTOP Washington· 2 days agoShares of the health care giant plunged Wednesday morning after the company said it was still...
What is behind the insulin shortage in the US?
Al Jazeera· 13 hours agoSkye Murphy, who is 22 years old, has lived with type 1 diabetes since she was 14. In the past month, she learned that there would be a 30-to-60-day...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
ABC News· 2 days agoCVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below...
Michael F. Cannon discusses the "donut hole" in Medicare coverage for drugs on The Bob Harden Show...
Cato Institute· 6 days agoApril 26, 2024
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
Associated Press via AOL· 2 days agoCVS Health missed first-quarter expectations and chopped its 2024 outlook more than a dollar below...
Opinion | Discerning the Truth About the Medicare Advantage Controversy
MedPage Today· 4 days agoFrom a clinical quality perspective, it's not complicated; Medicare Advantage (MA) works. As anyone...
UofL Health at odds with Medicare Advantage plans
WDRB 41 Louisville News· 6 days agoThousands of Medicare Advantage members in the Louisville area have been unable to access in-network care at Baptist Health for nearly four months. Now,...
Q1 2024 Cigna Group Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 hour agoIn our individual exchange business, we continue to sharpen our focus by repositioning our book through targeted actions in certain geographies. It's also important to note, we are making good ...
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
ClickOnDetroit· 2 days agoShares of the health care giant plunged Wednesday morning after the company said it was still...
